ストックスクリーナーアプリを入手
150.05
0.42%
-0.63
アフターアワーズ：
147.33
-2.72
-1.81%
前日終値:
$150.68
開ける：
$150.46
24時間の取引高:
456.03K
Relative Volume:
0.43
時価総額：
$10.03B
収益：
$13.64B
当期純損益:
$1.05B
株価収益率:
15.70
EPS:
9.555
ネットキャッシュフロー:
$1.31B
1週間 パフォーマンス:
+3.07%
1か月 パフォーマンス:
-0.99%
6か月 パフォーマンス:
+21.02%
1年 パフォーマンス:
-2.16%
1日の値動き範囲:
$149.26
$151.30
1週間の範囲:
$144.76
$153.00
52週間の値動き範囲:
$101.00
$159.42
Davita Inc Stock (DVA) Company Profile
Compare DVA vs HCA, THC, FMS, ENSG, UHS
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
150.05 | 10.07B | 13.64B | 1.05B | 1.31B | 9.555 |
HCA
Hca Healthcare Inc
|
495.47 | 113.39B | 75.60B | 7.78B | 7.69B | 28.38 |
THC
Tenet Healthcare Corp
|
195.24 | 17.56B | 21.31B | 2.37B | 2.53B | 15.49 |
FMS
Fresenius Medical Care Ag Adr
|
23.63 | 13.19B | 22.18B | 1.36B | 2.00B | 1.9216 |
ENSG
Ensign Group Inc
|
199.02 | 11.77B | 5.06B | 344.26M | 370.71M | 5.8446 |
UHS
Universal Health Services Inc
|
180.78 | 11.47B | 17.36B | 1.51B | 849.25M | 23.15 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-03-06 | 開始されました | Barclays | Equal Weight |
| 2023-08-07 | アップグレード | UBS | Neutral → Buy |
| 2022-11-01 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-10-31 | ダウングレード | UBS | Buy → Neutral |
| 2022-08-19 | 再開されました | UBS | Buy |
| 2022-06-21 | 繰り返されました | BofA Securities | Underperform |
| 2021-09-10 | 開始されました | Cowen | Market Perform |
| 2021-08-12 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2021-03-26 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2021-01-05 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-01-24 | アップグレード | Goldman | Neutral → Buy |
| 2019-11-07 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | アップグレード | UBS | Sell → Neutral |
| 2019-01-03 | 開始されました | Deutsche Bank | Buy |
| 2018-12-14 | 開始されました | Barclays | Overweight |
| 2018-11-28 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | 開始されました | UBS | Sell |
| 2018-11-08 | ダウングレード | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | アップグレード | JP Morgan | Underweight → Neutral |
| 2018-01-04 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | アップグレード | Citigroup | Neutral → Buy |
| 2017-12-07 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2017-06-26 | ダウングレード | Jefferies | Buy → Hold |
| 2016-12-13 | ダウングレード | Robert W. Baird | Outperform → Neutral |
すべてを表示
Davita Inc (DVA) 最新ニュース
DaVita Inc. stock (US23918K1088): Is its dialysis dominance strong enough to unlock new upside? - AD HOC NEWS
Here's why you should retain DaVita stock in your portfolio for now - MSN
DaVita HealthCare (DVA) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
Reasons to Keep DaVita Stock in Your Investment Portfolio at This Time - Bitget
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now - TradingView
Zacks Downgrades DaVita Stock Rating - National Today
DaVita Inc stock: What investors need to know about its dialysis dominance now - AD HOC NEWS
California law limiting dialysis providers' profits voided by US appeals court - Reuters
DaVita Clears Technical Benchmark, Hitting 80-Plus RS Rating - Investor's Business Daily
DaVita, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Day in the Life: Ansel, DaVita Home Hemodialysis Registered Nurse - CSRwire
DaVita's "Move It With Purpose" Sets Record Participation in Support of Global Health - csrwire.com
Day in the Life: Jena, DaVita Social Worker - CSRwire
Day in the Life: Cristina, DaVita PD Registered Nurse - CSRwire
DaVita Inc. stock underperforms Thursday when compared to competitors - MSN
DaVita Inc. (DVA) Stock Price, News, Quote & History - Yahoo! Finance Canada
DaVita Inc. (DVA.MX) Stock Price, News, Quote & History - Yahoo! Finance Canada
DaVita Entities’ Drug Purchases Exempt From Louisiana Sales Tax - news.bloombergtax.com
DaVita Inc. stock: Steady earnings beat amid market dips—what's next? - AD HOC NEWS
DaVita Arms Freed From Local La. Tax On Medicare Drugs - Law360
AMN Healthcare Services, DaVita, Bristol-Myers Squibb, Novavax, and AbbVie Shares Plummet, What You Need To Know - Yahoo Finance
DaVita HealthCare (DVA) Stock Dips While Market Gains: Key Facts - Yahoo Finance
DaVita Inc Stock: Leading Dialysis Provider Faces Evolving Healthcare Landscape in 2026 - AD HOC NEWS
DaVita: A Digital Guardian: AI-Powered Insights Bring Patients and Clinicians Closer - FinanzNachrichten.de
DVA Stock Price, Quote & Chart | DAVITA INC (NYSE:DVA) - ChartMill
DaVita Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
DaVita Inc. (DVA) Stock Forecasts - Yahoo Finance
Here's Why DaVita HealthCare (DVA) is a Strong Value Stock - Yahoo Finance
Here's Why DaVita HealthCare (DVA) Fell More Than Broader Market - Yahoo Finance
DaVita Inc. stock underperforms Monday when compared to competitors - MarketWatch
Heart Risks Go Beyond the Heart: Don’t Forget to Check Blood Sugar and Kidney Health - GlobeNewswire Inc.
Assenagon Asset Management Trims DaVita Stake - National Today
Assenagon Asset Management S.A. Trims Holdings in DaVita Inc. $DVA - MarketBeat
DaVita stock dips 1.49% as company promotes home dialysis benefits - Traders Union
Wedge Capital Management L L P NC Purchases 45,998 Shares of DaVita Inc. $DVA - MarketBeat
SG Americas Securities LLC Increases Stake in DaVita Inc. $DVA - MarketBeat
DaVita (FRA:TRL) PB Ratio : (As of Mar. 28, 2026) - GuruFocus
DaVita Inc. stock outperforms competitors despite losses on the day - MarketWatch
Why DaVita Inc (DVA) Is Set to Outperform the Market: Insights i - GuruFocus
DaVita Inc. (NYSE:DVA) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Should Value Investors Buy DaVita (DVA) Stock? - Yahoo Finance
Vanguard disaggregates holdings; DVA shows 0 shares (DVA) - Stock Titan
DaVita tops chart as the only large-cap healthcare services name rated strong buy - msn.com
Research Alert: CFRA Raises Rating On Shares Of Davita Inc. To Buy From Hold - Moomoo
DaVita Inc. stock faces scrutiny amid dialysis sector reimbursement pressures and Medicare policy sh - AD HOC NEWS
Flexibility of a Home Dialysis Nurse - CSRwire
Nordea Investment Management AB Boosts Holdings in DaVita Inc. $DVA - MarketBeat
DaVita, Inc. Experiences Revision in Stock Evaluation Amidst Market Dynamics - Markets Mojo
How Investors Are Reacting To DaVita (DVA) CKCC Savings And Value-Based Kidney Care Momentum - Sahm
Hedge Fund Moves: Can DaVita Inc continue delivering strong returnsGap Up & Trade Opportunity Analysis Reports - baoquankhu1.vn
Davita Inc (DVA) 財務データ
収益
当期純利益
現金流量
EPS
1.00%
0.08%
大文字化:
|
ボリューム (24 時間):